Yes, it is a beneficial tool because the old-fashioned way of talking about risk was to say that someone had two-times the risk or 1.5-times the risk of the general population for something untoward ...

The easily calculated Male Osteoporosis Risk Estimation Score (MORES), based on clinical risk factors alone, is a more effective screening tool for osteoporosis in men than the web-based, more complex ...

FRAX® is a computer-based algorithm to help predict the 10-year risk of fragility fracture. Now with 34 specific country models, FRAX is being used increasingly by physicians around the world to help ...

Good news for the many health professionals and researchers who depend on FRAX® to assess fracture risk in their patients: The essential internet-based tool can now be downloaded as a stand-alone ...

MINNEAPOLIS, Minnesota — The Fracture Risk Assessment Tool (FRAX), recommended by the US Preventive Services Task Force (USPSTF) to identify younger postmenopausal women at risk for osteoporosis, ...

The World Health Organization’s tool for assessing bone fracture risk underestimates the true dangers for people who are younger than 65 or have been treated for a single broken bone, according to a ...

Three days of critical international discussion and debate, led by a panel of experts from the International Society of Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF) ...

Please provide your email address to receive an email when new articles are posted on . The World Health Organization (WHO) Fracture Risk Assessment Tool (FRAX) is now easily accessible via iPhone, ...

The FRAX ® tool takes into account certain factors to determine the risk of bone fracture in the general population. In a Journal of Bone and Mineral Research study, the tool was effective at ...

—Although FRAX does not have specific inputs for cancer and cancer treatments, may be an accurate predictor of fracture risk in patients with cancer, especially when BMD is included. Fractures due to ...

Trends in androgen-deprivation therapy use among privately insured men with prostate cancer, 2001-2010. FRAX without BMD and T-score-0.318 < 0.005 This is an ASCO Meeting Abstract from the 2014 ASCO ...